Sean Ellis's Insider Trades & SAST Disclosures
Sean Ellis's most recent trade in Entera Bio Ltd was a trade of 28,509 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sean Ellis.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Entera Bio Ltd | Sean Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 28,509 | 28,509 | - | - | Stock Option (right to buy) | |
| Entera Bio Ltd | Sean Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 7,100 | 134,727 (1%) | 0% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
| Entera Bio Ltd | Sean Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 7,466 | 127,627 (1%) | 0% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
| Entera Bio Ltd | Sean Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 18,061 | 120,161 (1%) | 0% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
| Entera Bio Ltd | Ellis Sean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 108,333 | 108,333 | - | - | Stock Option (right to buy) | |
| Entera Bio Ltd | Sean Ellis | Director | Purchase of securities on an exchange or from another person at price $ 0.60 per share. | 21 Aug 2023 | 40,000 | 102,100 (0%) | 0% | 0.6 | 24,000 | Ordinary Shares, par value NIS 0.0000769 per share |
| Entera Bio Ltd | Sean Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 89,041 | 89,041 | - | - | Stock Option (right to buy | |
| Entera Bio Ltd | Sean Ellis | Director | Purchase of securities on an exchange or from another person at price $ 0.53 per share. | 11 Nov 2022 | 30,000 | 62,100 (0%) | 0% | 0.5 | 15,900 | Ordinary Shares, par value NIS 0.0000769 per share |
| Entera Bio Ltd | Sean Ellis | Director | Purchase of securities on an exchange or from another person at price $ 1.64 per share. | 21 Jul 2022 | 14,900 | 32,100 (0%) | 0% | 1.6 | 24,406 | Ordinary Shares, par value NIS 0.0000769 per share |
| Entera Bio Ltd | Sean Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 107,557 | 107,557 | - | - | Stock Option (right to buy) | |
| Entera Bio Ltd | Sean Ellis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 35,852 | 35,852 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges